🇺🇸 FDA
Patent

US 10195168

Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders

granted A61KA61K31/19A61K31/554

Quick answer

US patent 10195168 (Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders) held by Jazz Pharmaceuticals Ireland Limited expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Jazz Pharmaceuticals Ireland Limited
Grant date
Tue Feb 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/19, A61K31/554, A61K9/0053, A61K9/08